MH
Insider
Michael B Hoffman
DirectorMichael B Hoffman (Director) filed 6 Form 4 reports in the trailing twelve months (6 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in Annovis Bio, Inc. (ANVS). Across 5 priced purchase filings, the average 21-session return was +21.1% from execution and +6.9% from disclosure (delay-adjusted; derived). The largest single filing was $2.0M of ANVS (975,610 sh × $2.05, as filed), executed Oct 28 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+21.1%
avg across 5 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+6.9%
same 5 filings, from disclosure
Filings, ttm
6
6 buys · 0 sells · 1 late
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.0M
shares × price, as filed
Last traded
May 20
Filed May 21
Impact on $10,000 · 12M
$15,147 (+51.5%)
S&P 500 $11,725 (+17.2%) · 34.2 pts ahead
Michael B Hoffman
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $4.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
ANVSRecent filings
ANVSPURCHASE
Annovis Bio, Inc.
View filing →
$104K54,933 sh × $1.90
Exec May 20
Filed May 21 · 8:11 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $1.5M
713,800 sh × $2.10
Exec Apr 2
Filed Apr 3 · 5:06 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $130K
30,000 sh × $4.34
Exec Dec 8 2025
Filed Dec 8 2025 · 8:05 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 6:59 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 12:26 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $2.0M
975,610 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:18 AM ET †